INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/11/2025
Voltar para busca
Dado oficial do USPTO
STA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
05/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 40, 42
Data de depósito
10/07/2012
Data de registro
29/04/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/10/2024
Última transação
05/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
Shanghai, CN
Examinador
AWRICH,ELLEN
Localização atual
Historical data usage
Descrição da marca
The mark consists of three highly stylized English letters "S", "T", and "A", to the right of an eight sided geometric design formed by four segments wherein none of the segments connects to the adjacent segment.
Titulares e representantes
Titulares
Shanghai SynTheAll Pharmaceutical Co., Ltd.
Shanghai SynTheAll; Pharmaceutical Co., Ltd.
Representantes
Colleen Flynn Goss Lippes Mathias LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Alkaloids for industrial purposes; alkaloids for the manufacture of synthetic drugs; alkaloids for medical purposesmedical research; acidsboracic acidcarbonic acidbenzene-based acidcitric acid; alkalies; protein in raw material form for scientific and medical research; unprocessed artificial and synthetic resins
Classe 5
Medicines for human purposesanti-allergic medicines; prescription and non-prescription medicines for human purposes for the prevention and treatment of dermatological and gynecological diseases; bacteriological preparations for medical and veterinary use; miconazole nitrate for use in the manufacture of medicinesanti-allergic medicinesprescription and non-prescription medicines for the prevention and treatment of bacterialdermatological and gynecological diseases
Classe 40
Synthesizing and improving chemical reagentsrefiningdrying and grinding chemical reagents; handling of chemical reagentsdryingfiltering and grinding ; processing of medicinal materialscustom manufacturing of pharmaceuticalsanti-allergic drugsprescription and non-prescription medicines for the prevention and treatment of dermatologicalbacterialgynecological diseases by pharmaceutical compounders
Classe 42
Technical research in the field of pharmaceuticals; research and development for others in the field of pharmaceuticals; chemical analysis; chemistry servicesresearching of production methods for manufacturing or transforming the substance in the laboratory and mass produced in factories; chemistry consultationproviding clients with detailed methods for chemistry production and quality testing; chemical research ; biological research
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/06/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/10/2024
71AG
REGISTERED-SEC.71 ACCEPTED
11/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/10/2024
ES71
TEAS SECTION 71 RECEIVED
06/02/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29/04/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
29/07/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/10/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
27/08/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
27/08/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
14/08/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
14/12/2020
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
14/12/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/12/2020
ES71
TEAS SECTION 71 RECEIVED
17/08/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/04/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/09/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2014
FIMP
FINAL DISPOSITION PROCESSED
05/09/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/07/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
29/04/2014
GPNX
NOTIFICATION PROCESSED BY IB
11/02/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2014
PUBO
PUBLISHED FOR OPPOSITION
11/02/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/01/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/01/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/01/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/01/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
18/12/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/12/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
18/12/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/12/2013
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
02/04/2013
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
01/04/2013
ALIE
ASSIGNED TO LIE
30/03/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2013
RFNT
REFUSAL PROCESSED BY IB
08/01/2013
MAFR
APPLICATION FILING RECEIPT MAILED
21/12/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/12/2012
RFRR
REFUSAL PROCESSED BY MPU
18/12/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/12/2012
CNRT
NON-FINAL ACTION WRITTEN
17/12/2012
DOCK
ASSIGNED TO EXAMINER
17/12/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/12/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/12/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.